Evidence map›Paper›PMID 34745513›Full record

ArticleJournal of healthcare engineering2021

Classification of Benign and Malignant Lung Nodules Based on Deep Convolutional Network Feature Extraction.

Enhui Lv, Wenfeng Liu, Pengbo Wen, Xingxing Kang

Abstract read
In one paragraph

Article in Journal of healthcare engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Enhui LvSchool of Medical Information & Engineering, Xuzhou Medical University, Xuzhou 221004, China.
Wenfeng LiuDepartment of Information Center, Weihai Ocean Vocational College, Rongcheng 264300, China.
Pengbo WenSchool of Medical Information & Engineering, Xuzhou Medical University, Xuzhou 221004, China.ORCID 0000-0002-3017-0137
Xingxing KangSchool of Medical Information & Engineering, Xuzhou Medical University, Xuzhou 221004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development of detection technology, CT imaging technology has been widely used in the early clinical diagnosis of lung nodules. However, accurate assessment of the nature of the nodule remains a challenging task due to the subjective nature of the radiologist. With the increasing amount of publicly available lung image data, it has become possible to use convolutional neural networks for benign and malignant classification of lung nodules. However, as the network depth increases, network training methods based on gradient descent usually lead to gradient dispersion. Therefore, we propose a novel deep convolutional network approach to classify the benignity and malignancy of lung nodules. Firstly, we segmented, extracted, and performed zero-phase component analysis whitening on images of lung nodules. Then, a multilayer perceptron was introduced into the structure to construct a deep convolutional network. Finally, the minibatch stochastic gradient descent method with a momentum coefficient is used to fine-tune the deep convolutional network to avoid the gradient dispersion. The 750 lung nodules in the lung image database are used for experimental verification. Classification accuracy of the proposed method can reach 96.0%. The experimental results show that the proposed method can provide an objective and efficient aid to solve the problem of classifying benign and malignant lung nodules in medical images.

Indexed as

Lung NeoplasmsSolitary Pulmonary NoduleHumansLungNeural Networks, ComputerTomography, X-Ray Computed

Identifiers

PMID34745513
PMCPMC8566059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.